Steven N. Goodman

Last updated
Steven N Goodman
CitizenshipAmerican
EducationAB, Harvard College, Biochemistry, Applied Math (1976)
Alma mater Harvard University
New York University
Johns Hopkins School of Public Health;
Known for"Toward Evidence-Based Medical Statistics. 1: The P Value Fallacy, and 2: The Bayes Factor"
AwardsSpinoza Chair in Medicine (2016), National Academy of Medicine (2020)
Scientific career
FieldsMedical Research, Epidemiology, Statistics, Metascience
Thesis Evidence and Clinical Trials  (1989)
Doctoral advisor Richard Royall
Other academic advisorsCurt Meinert

Steven N. Goodman (born 1954) is an American Professor of Epidemiology and Population Health and of Medicine at the Stanford School of Medicine. [1] He has extensively contributed to foundations of scientific and statistical inference within the biosciences, and in 1999 he coined the term "p-value fallacy". [2]

Contents

Works

He has made numerous contributions to the methods of clinical research, comparative effectiveness, meta analysis, and scientific inference, [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] in addition to works on scientific evidence. [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28]

Related Research Articles

<span class="mw-page-title-main">Rectal examination</span> Medical assessment or diagnostic procedure

Digital rectal examination (DRE), also known as a prostate exam, is an internal examination of the rectum performed by a healthcare provider.

Neuraminidase inhibitors (NAIs) are a class of drugs which block the neuraminidase enzyme. They are a commonly used antiviral drug type against influenza. Viral neuraminidases are essential for influenza reproduction, facilitating viral budding from the host cell. Oseltamivir (Tamiflu), zanamivir (Relenza), laninamivir (Inavir), and peramivir belong to this class. Unlike the M2 inhibitors, which work only against the influenza A virus, NAIs act against both influenza A and influenza B.

The McMurray test, also known as the McMurray circumduction test is used to evaluate individuals for tears in the meniscus of the knee. A tear in the meniscus may cause a pedunculated tag of the meniscus which may become jammed between the joint surfaces.

<i>Annals of Internal Medicine</i> American academic journal

Annals of Internal Medicine is an academic medical journal published by the American College of Physicians (ACP). It is one of the most widely cited and influential specialty medical journals in the world. Annals publishes content relevant to the field of internal medicine and related sub-specialties. Annals publishes a wide variety of original research, review articles, practice guidelines, and commentary relevant to clinical practice, health care delivery, public health, health care policy, medical education, ethics, and research methodology. In addition, the journal publishes personal narratives that convey the feeling and the art of medicine. Selected articles in the journal are freely available; these include patient-oriented content and Clinical Guidelines.

An auscultatory gap, also known as the silent gap, is a period of diminished or absent Korotkoff sounds during the manual measurement of blood pressure. It is associated with peripheral blood flow caused by changes in the pulse wave. The improper interpretation of this gap may lead to blood pressure monitoring errors, such as an underestimation of systolic blood pressure and/or an overestimation of diastolic blood pressure. In order to correct for an auscultatory gap, the radial pulse should be monitored by palpation. It is therefore recommended to palpate and auscultate when manually recording a patient's blood pressure. Typically, the blood pressure obtained via palpation is around 10 mmHg lower than the pressure obtained via auscultation. In general, the examiner can avoid being confused by an auscultatory gap by always inflating a blood pressure cuff to 20-40 mmHg higher than the pressure required to occlude the brachial pulse.

The United States Preventive Services Task Force (USPSTF) is "an independent panel of experts in primary care and prevention that systematically reviews the evidence of effectiveness and develops recommendations for clinical preventive services". The task force, a volunteer panel of primary care clinicians with methodology experience including epidemiology, biostatistics, health services research, decision sciences, and health economics, is funded, staffed, and appointed by the U.S. Department of Health and Human Services' Agency for Healthcare Research and Quality.

A seeding trial or marketing trial is a form of marketing, conducted in the name of research, designed to target product sampling towards selected consumers. In the marketing research field, seeding is the process of allocating marketing to specific customers, or groups of customers, in order to stimulate the internal dynamics of the market, and enhance the diffusion process. In medicine, seeding trials are clinical trials or research studies in which the primary objective is to introduce the concept of a particular medical intervention—such as a pharmaceutical drug or medical device—to physicians, rather than to test a scientific hypothesis. In the E-commerce industry, seeding trials are often referred to as product seeding.

An N of 1 trial (N=1) is a multiple crossover clinical trial, conducted in a single patient. A trial in which random allocation is used to determine the order in which an experimental and a control intervention are given to a single patient is an N of 1 randomized controlled trial. Some N of 1 trials involve randomized assignment and blinding, but the order of experimental and control interventions can also be fixed by the researcher.

The Enhancing the Quality and Transparency of health research Network is an international initiative aimed at promoting transparent and accurate reporting of health research studies to enhance the value and reliability of medical research literature. The EQUATOR Network is hosted by the University of Oxford, and was established with the goals of raising awareness of the importance of good reporting of research, assisting in the development, dissemination and implementation of reporting guidelines for different types of study designs, monitoring the status of the quality of reporting of research studies in the health sciences literature, and conducting research relating to issues that impact the quality of reporting of health research studies. The Network acts as an "umbrella" organisation, bringing together developers of reporting guidelines, medical journal editors and peer reviewers, research funding bodies, and other key stakeholders with a mutual interest in improving the quality of research publications and research itself. The EQUATOR Network comprises five centres at the University of Oxford, Bond University, Paris Descartes University, Ottawa Hospital Research Institute, and Hong Kong Baptiste University.

Unnecessary health care is health care provided with a higher volume or cost than is appropriate. In the United States, where health care costs are the highest as a percentage of GDP, overuse was the predominant factor in its expense, accounting for about a third of its health care spending in 2012.

Elizabeth Knight Dawson is a biostatistician and biostatistics textbook author.

<span class="mw-page-title-main">Thomas P. Loughran Jr.</span> American physician-scientist

Thomas P. Loughran, Jr. is an American physician-scientist who specializes in cancer research and treatment. He became director of the University of Virginia Cancer Center, F. Palmer Weber-Smithfield Foods Professor of Oncology Research and Professor of Medicine at the University of Virginia on August 15, 2013. Between 2003 and 2013, Loughran served as the founding director of the Penn State Hershey Cancer Institute and professor of medicine at the Penn State College of Medicine. His previous appointments included program leader of hematologic malignancies at the H. Lee Moffitt Cancer Center & Research Institute at the University of South Florida, associate director of the Bone Marrow Transplant Program at SUNY Health Science Center and chief of hematology at the Syracuse Veteran's Affairs Medical Center in Syracuse, New York. Loughran completed his fellowship in medical oncology in 1985 at the Fred Hutchinson Cancer Research Center in Seattle, Washington under direction of Nobel Laureate E. Donnall Thomas. He remained on faculty there for seven years. Loughran earned his medical degree from Hahnemann Medical School in Philadelphia in 1979.

Patient satisfaction is a measure of the extent to which a patient is content with the health care which they received from their health care provider.

A rectovaginal examination is a type of gynecological examination used to supplement a pelvic examination. In the rectovaginal examination, a doctor or other health care provider places one finger in the vagina and another in the rectum to assess the rectovaginal septum. The examiner will look for any scarring or masses that may indicate cancer or another disease. Typically, a rectovaginal examination is performed to assess pelvic pain, rectal symptoms, or a pelvic mass. It can also provide a sample for fecal occult blood testing.

The STEPS trial was a clinical trial sponsored by Parke-Davis to evaluate the anticonvulsant Neurontin. It is notable for being a seeding trial to promote that drug and for contributing to the drug companies loss in the court case Franklin v. Parke-Davis.

Kathleen I. Pritchard, is the head of oncology at Sunnybrook Health Sciences Centre in Toronto, Canada, specializing in breast cancer therapies, and leading the clinical trials division of the centre. She has authored numerous studies on women's health, breast cancer, hormone replacement therapy, public health, and research methodology. According to Thomson Reuters, Pritchard was one of the most cited researchers in the world in 2014 and 2015.

<span class="mw-page-title-main">Vineet M. Arora</span> American medical researcher

Vineet M. Arora is an American medical researcher who is the Herbert T. Abelson Professor of Medicine and Dean for Medical Education at the University of Chicago Pritzker School of Medicine. She is a Fellow of the National Academy of Medicine. Her research considers clinical medicine and medical education, with a focus on the improvement of the quality of care in teaching hospitals.

<span class="mw-page-title-main">Redento D. Ferranti</span> American-Italian pulmonologist (1923-2008)

Redento D. Ferranti was born in Sulmona, Italy, and was a pioneer in the United States in the field of care for chronic respiratory patients and pulmonary rehabilitation. Ferranti was one of the first to introduce long term oxygen therapy in the U.S. as an effective approach to rehabilitation for COPD patients, and was one of the first physicians to introduce the use of liquid oxygen in small portable containers. His early work in the field of pulmonology earned him the title "father of modern pulmonary rehabilitation." He was a staff physician, director of pulmonary medicine, and medical director at Gaylord Hospital in Wallingford, Connecticut, from 1969 to 1997, and an Associate Clinical Professor of Medicine at Yale University. Ferranti was instrumental in developing Gaylord Hospital's treatment of pulmonary patients and was an early champion of sleep studies, leading the hospital's largest sleep study program in New England and one of the largest in the country. He received many awards including The American Lung Association and Connecticut Thoracic Society's Humanitarian Award and the Gaylord Medal.

Eve Askanas Kerr is an American physician-researcher. Kerr is a Full Professor of internal medicine and the inaugural Vice-Chair of Diversity, Equity, and Well-being at the University of Michigan.

The Wells score is a clinical prediction rule used to classify patients suspected of having pulmonary embolism (PE) into risk groups by quantifying the pre-test probability. It is different than Wells score for DVT. It was originally described by Wells et al. in 1998, using their experience from creating Wells score for DVT in 1995. Today, there are multiple versions of the rule, which may lead to ambiguity.

References

  1. ↑ "Steven Goodman".
  2. ↑ Sellke, Thomas; Bayarri, M. J; Berger, James O (February 2001). "Calibration of ρ Values for Testing Precise Null Hypotheses". The American Statistician. 55 (1): 62–71. doi:10.1198/000313001300339950. S2CID   396772.
  3. ↑ Cornell, J. E., Mulrow, C. D., Localio, R., Stack, C. B., Meibohm, A. R., Guallar, E., Goodman, S. N. (2014). "Random-Effects Meta-analysis of Inconsistent Effects: A Time for Change". Annals of Internal Medicine. 160 (4): 267–270. doi:10.7326/M13-2886. PMID   24727843. S2CID   9210956.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  4. ↑ Basch, E., Aronson, N., Berg, A., Flum, D., Gabriel, S., Goodman, S. N., Helfand, M., Ioannidis, J. P., Lauer, M., Meltzer, D., Mittman, B., Newhouse, R., Normand, S., Schneeweiss, S., Slutsky, J., Tinetti, M., Yancy, C. (2012). "Methodological Standards and Patient-Centeredness in Comparative Effectiveness Research The PCORI Perspective". JAMA. 307 (15): 1636–1640. doi:10.1001/jama.2012.466. PMID   22511692.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  5. ↑ Goodman, S. N. (2012). "Quasi-random reflections on randomized controlled trials and comparative effectiveness research". Clinical Trials. 9 (1): 22–26. doi:10.1177/1740774511433285. PMID   22334465. S2CID   22693531.
  6. ↑ Sox, H. C., Goodman, S. N. (2012). "The Methods of Comparative Effectiveness Research". Annual Review of Public Health. 33: 425–445. doi: 10.1146/annurev-publhealth-031811-124610 . PMID   22224891.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  7. ↑ Goodman, S., Dickersin, K. (2011). "Metabias: A Challenge for Comparative Effectiveness Research". Annals of Internal Medicine. 155 (1): 61–2. doi:10.7326/0003-4819-155-1-201107050-00010. PMID   21727295. S2CID   43451703.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  8. ↑ Luce, B. R., Kramer, J. M., Goodman, S. N., Connor, J. T., Tunis, S., Whicher, D., Schwartz, J. S. (2009). "Rethinking Randomized Clinical Trials for Comparative Effectiveness Research: The Need for Transformational Change". Annals of Internal Medicine. 151 (3): 206–209. doi: 10.7326/0003-4819-151-3-200908040-00126 . PMID   19567619.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  9. ↑ Goodman SN, Greenland S (2007). "Assessing the unreliability of the medical literature: A response to "Why most published research findings are false"". Archived from the original on 2012-04-06.{{cite journal}}: Cite journal requires |journal= (help)
  10. ↑ Goodman, S. N. (2002). "The mammography dilemma: A crisis for evidence-based medicine?". Annals of Internal Medicine. 137 (5): 363–365. doi:10.7326/0003-4819-137-5_part_1-200209030-00015. PMID   12204023. S2CID   40784168.
  11. ↑ Goodman, S. N., Zahurak, M. L., PIANTADOSI, S. (1995). "Some practical improvements in the continual reassessment method for phase I studies". Statistics in Medicine. 14 (11): 1149–1161. doi:10.1002/sim.4780141102. PMID   7667557.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  12. ↑ Goodman, S. N., Berlin, J. A. (1994). "The Use of Predicted Confidence Intervals when Planning Experiments and the Misuse of Power when Interpreting Results". Annals of Internal Medicine. 121 (3): 200–206. doi:10.7326/0003-4819-121-3-199408010-00008. PMID   8017747. S2CID   53089940.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  13. ↑ Goodman, S. N. (1989). "Meta-analysis and evidence". Controlled Clinical Trials. 10 (2): 188–204. doi: 10.1016/0197-2456(89)90030-5 . PMID   2666026.
  14. ↑ Goodman, S. N., Royall, R. (1988). "Evidence and scientific research". American Journal of Public Health. 78 (12): 1568–1574. doi:10.2105/ajph.78.12.1568. PMC   1349737 . PMID   3189634.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  15. ↑ Glass, T. A., Goodman, S. N., Hernán, M. A., Samet, J. M. (2013). "Causal inference in public health". Annual Review of Public Health. 34: 61–75. doi:10.1146/annurev-publhealth-031811-124606. PMC   4079266 . PMID   23297653.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  16. ↑ Faden, R. R., Kass, N. E., Goodman, S. N., Pronovost, P., Tunis, S., Beauchamp, T. L. (2013). "An Ethics Framework for a Learning Health Care System: A Departure from Traditional Research Ethics and Clinical Ethics". Hastings Center Report. 43: S16-27. doi:10.1002/hast.134. PMID   23315888.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  17. ↑ Kass, N. E., Faden, R. R., Goodman, S. N., Pronovost, P., Tunis, S., Beauchamp, T. L. (2013). "The Research-Treatment Distinction: A Problematic Approach for Determining Which Activities Should Have Ethical Oversight". Hastings Center Report. 43: S4–S15. doi:10.1002/hast.133. PMID   23315895.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  18. ↑ Mello, M. M., Goodman, S. N., Faden, R. R. (2012). "Ethical Considerations in Studying Drug Safety - The Institute of Medicine Report". New England Journal of Medicine. 367 (10): 959–964. doi: 10.1056/NEJMhle1207160 . PMID   22913661. S2CID   36551817.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  19. ↑ Goodman, S. (2011). "Confessions of a chagrined trialist". BMJ Quality & Safety. 20 (Suppl_1): i97–i98. doi:10.1136/bmjqs.2010.046623. PMC   3066790 . PMID   21450783.
  20. ↑ Goodman, S. N. (2007). "Stopping at nothing? Some dilemmas of data monitoring in clinical trials". Annals of Internal Medicine. 146 (12): 882–887. doi:10.7326/0003-4819-146-12-200706190-00010. PMID   17577008. S2CID   21243453.
  21. ↑ Laine, C., Goodman, S. N., Griswold, M. E., Sox, H. C. (2007). "Reproducible research: Moving toward research the public can really trust". Annals of Internal Medicine. 146 (6): 450–453. doi:10.7326/0003-4819-146-6-200703200-00154. PMID   17339612. S2CID   1359523.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  22. ↑ Goodman, S. N., Sladky, J. T. (2005). "A Bayesian approach to randomized controlled trials in children utilizing information from adults: the case of Guillain–Barre syndrome". Clinical Trials. 2 (4): 305–310. doi:10.1191/1740774505cn102oa. PMID   16281429. S2CID   22919090.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  23. ↑ Goodman, S. N. (2001). "Of P-values and bayes: A modest proposal". Epidemiology. 12 (3): 295–297. doi: 10.1097/00001648-200105000-00006 . PMID   11337600. S2CID   41986475.
  24. ↑ Goodman, S. N. (1999). "Toward evidence-based medical statistics. 1: The P value fallacy". Annals of Internal Medicine. 130 (12): 995–1004. doi:10.7326/0003-4819-130-12-199906150-00008. PMID   10383371. S2CID   7534212.
  25. ↑ Goodman, S. N. (1999). "Toward evidence-based medical statistics. 2: The Bayes factor". Annals of Internal Medicine. 130 (12): 1005–1013. doi:10.7326/0003-4819-130-12-199906150-00019. PMID   10383350. S2CID   13186212.
  26. ↑ Goodman, S. N., Berlin, J., Fletcher, S. W., Fletcher, R. H. (1994). "Manuscript Quality before and after Peer Review and Editing at Annals of Internal Medicine". Annals of Internal Medicine. 121 (1): 11–21. doi:10.7326/0003-4819-121-1-199407010-00003. PMID   8198342. S2CID   5716602.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  27. ↑ Goodman, S. N. (1993). "P Values, Hypothesis Tests, and Likelihood: Implications for Epidemiology of a Neglected Historical Debate". American Journal of Epidemiology. 137 (5): 485–496. doi:10.1093/oxfordjournals.aje.a116700. PMID   8465801.
  28. ↑ Goodman, S. N. (1992). "A comment on replication, P-values and evidence". Statistics in Medicine. 11 (7): 875–879. doi:10.1002/sim.4780110705. PMID   1604067.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.